XBIT
NASD XBiotech, Inc.$2.29 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.29, and at the day’s high of $2.29
- YTD change
- -4.18%
- vs 20-day SMA
- +5.08%
- vs 200-day SMA
- -2.97%
Price ranges
Price & Performance
-0.04 (-1.72%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 91.3% away from all-time highs of $26.40
- XBIT is down 4% since the beginning of the year
- XBIT is down 12% over the past 12 months
- XBIT is up 6% over the past 1 month
- 1% of all XBIT investors are betting against XBIT
XBIT reads very good: price sits above one of the two key moving averages, the 12-month move is -9.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +4.09%
- vs 8-day SMA
- +4.75%
No alerts for XBIT in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.